Monopar Therapeutics (MNPR) Misses Q1 EPS by 46c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics (NASDAQ: MNPR) reported Q1 EPS of ($0.46).
For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin Said To Plan Ukraine Escalation, Seeing Talks Fruitless - Bloomberg
- Williams-Sonoma (WSM) Tops Q2 EPS by 4c
- JinkoSolar (JKS) Misses Q2 EPS by RMB 7.10, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
